✦ LIBER ✦

HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancer

✍ Scribed by Lipton, Allan; Goodman, Laurie; Leitzel, Kim; Cook, Jennifer; Sperinde, Jeff; Haddad, Mojgan; Köstler, Wolfgang J.; Huang, Weidong; Weidler, Jodi M.; Ali, Suhail; Newton, Alicia; Fuchs, Eva-Marie; Paquet, Agnes; Singer, Christian F.; Horvat, Reinhard; Jin, Xueguang; Banerjee, Joyee; Mukherjee, Ali; Tan, Yuping; Shi, Yining; Chenna, Ahmed; Larson, Jeff; Lie, Yolanda; Sherwood, Thomas; Petropoulos, Christos J.; Williams, Stephen; Winslow, John; Parry, Gordon; Bates, Michael

Book ID: 121626553
Publisher: Springer US
Year: 2013
Tongue: English
Weight: 599 KB
Volume: 141
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-013-2665-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In situ detection of HER2:HER2 and HER2:

In situ detection of HER2:HER2 and HER2:HER3 protein–protein interactions demonstrates prognostic significance in early breast cancer

✍ Melanie Spears; Karen J. Taylor; Alison F. Munro; Carrie A. Cunningham; Elizabet 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 401 KB

Methodology matters – prognostic signifi

Methodology matters – prognostic significance of HER2 protein expression versus HER2 gene amplification in metastatic breast cancer

✍ N. Todorovic-Rakovic; D. Jovanovic; Z. Neskovic-Konstantinovic; D. Nikolic-Vukos 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Immunohistochemical expression of HER1,

Immunohistochemical expression of HER1, HER3, and HER4 in HER2-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy

✍ Kan Yonemori; Koji Tsuta; Chikako Shimizu; Yutaka Hatanaka; Akihiro Hirakawa; Ma 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

3–35 HER-2 Amplification, HER-1 Expressi

3–35 HER-2 Amplification, HER-1 Expression, and Tamoxifen Response in Estrogen Receptor-Positive Metastatic Breast Cancer: A Southwest Oncology Group Study

✍ Ellis, M.J. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Issues and controversies in the treatmen

Issues and controversies in the treatment of HER2 positive metastatic breast cancer

✍ Surabhi Amar; Alvaro Moreno-Aspitia; Edith A. Perez 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 153 KB

Prognostic value of HER-2/neu and p53 ex

Prognostic value of HER-2/neu and p53 expression in node-positive breast cancer. HER-2/neu effect on adjuvant tamoxifen treatment

✍ M.A. Climent; M.A. Seguı́; G. Peiró; R. Molina; E. Lerma; B. Ojeda; J.J. López-L 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 219 KB